The National Cancer Institute (NCI) is offering this grant opportunity to support revision applications from currently funded NCI R01 research projects. This grant is for the purpose of expanding original research questions or accelerating progress in parent studies by incorporating novel technical approaches or instruments. These technologies must have been developed through the NCI Innovative Molecular Analysis Technologies (IMAT) program. The primary goal of this funding is to incentivize independent validation and accelerate the adoption of these emerging technologies within the research community. As a component of the NCI IMAT program, this initiative aims to promote crucial interdisciplinary collaboration, facilitating the development of innovative tools and methods essential for advancing cancer research and accelerating scientific discovery.
Opportunity ID: 337194
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-22-005 |
| Funding Opportunity Title: | Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 04, 2022 |
| Last Updated Date: | Jan 04, 2022 |
| Original Closing Date for Applications: | Sep 22, 2022 |
| Current Closing Date for Applications: | Sep 22, 2022 |
| Archive Date: | Oct 28, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $150,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) City or township governments Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) For profit organizations other than small businesses State governments Public housing authorities/Indian housing authorities Private institutions of higher education Special district governments County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI R01 research projects. The applicants should propose to expand upon the original research question(s) or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the adoption of these emerging technologies by appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-005.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 337194 Full Announcement-RFA-CA-22-005 -> RFA-CA-22-005-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00271217 | Mar 22, 2022 | Sep 22, 2022 | View |
Package 1
Mandatory forms
337194 RR_SF424_5_0-5.0.pdf
337194 PHS398_CoverPageSupplement_5_0-5.0.pdf
337194 RR_OtherProjectInfo_1_4-1.4.pdf
337194 PerformanceSite_4_0-4.0.pdf
337194 RR_KeyPersonExpanded_4_0-4.0.pdf
337194 PHS398_ResearchPlan_4_0-4.0.pdf
337194 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
337194 RR_Budget_3_0-3.0.pdf
337194 RR_SubawardBudget30_3_0-3.0.pdf
337194 PHS398_ModularBudget_1_2-1.2.pdf
337194 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
